IRIS PubliCatt

Bosello, Silvia Laura
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.965
NA - Nord America 2.816
AS - Asia 1.124
AF - Africa 16
OC - Oceania 12
SA - Sud America 11
Continente sconosciuto - Info sul continente non disponibili 9
Totale 6.953
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.793
DE - Germania 944
IT - Italia 511
SE - Svezia 471
CN - Cina 438
SG - Singapore 348
FR - Francia 233
UA - Ucraina 226
IE - Irlanda 177
ID - Indonesia 125
GB - Regno Unito 108
IN - India 101
RU - Federazione Russa 74
PL - Polonia 70
FI - Finlandia 61
TR - Turchia 45
BE - Belgio 37
CA - Canada 22
IR - Iran 20
HK - Hong Kong 19
AU - Australia 12
CI - Costa d'Avorio 11
JP - Giappone 11
CZ - Repubblica Ceca 8
NL - Olanda 8
RO - Romania 8
ES - Italia 6
EU - Europa 6
DK - Danimarca 5
KR - Corea 5
CO - Colombia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BR - Brasile 3
CH - Svizzera 3
LT - Lituania 3
MY - Malesia 3
NG - Nigeria 3
AR - Argentina 2
BG - Bulgaria 2
CL - Cile 2
HU - Ungheria 2
SA - Arabia Saudita 2
SI - Slovenia 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BY - Bielorussia 1
BZ - Belize 1
CY - Cipro 1
EG - Egitto 1
GE - Georgia 1
LU - Lussemburgo 1
MD - Moldavia 1
PK - Pakistan 1
PT - Portogallo 1
TH - Thailandia 1
TW - Taiwan 1
UG - Uganda 1
Totale 6.953
Salva come PNG Salva come JPEG
Città #
Chandler 590
Singapore 274
Ashburn 224
Dublin 176
Ann Arbor 173
Jacksonville 132
Jakarta 125
Dearborn 121
San Mateo 96
Wilmington 88
Woodbridge 84
Nanjing 82
New York 80
Milan 78
Houston 72
Rome 68
Seattle 68
Kraków 64
Fairfield 61
Moscow 56
Munich 54
Nürnberg 48
Boston 46
Lawrence 42
Marseille 42
Beijing 41
Izmir 39
Cattolica 37
Brussels 36
Bremen 34
Nanchang 34
Pune 31
Redwood City 28
Princeton 25
Hebei 23
Norwalk 23
Kunming 21
Guangzhou 19
Boardman 18
Los Angeles 18
Lancaster 17
Leawood 16
Tianjin 16
Trieste 16
Augusta 15
Cambridge 15
Falls Church 15
Fremont 15
Paris 15
Hong Kong 14
Andover 13
Chicago 13
Helsinki 13
Detroit 12
Frankfurt am Main 12
Abidjan 11
Mountain View 11
Redmond 11
Toronto 11
University Park 11
Hangzhou 10
Jiaxing 10
London 10
Shanghai 10
Shenyang 10
Zhengzhou 9
Changsha 8
Florence 8
Kish 8
Hefei 7
Palermo 7
Monmouth Junction 6
Santa Clara 6
Ardabil 5
Brno 5
Busto Arsizio 5
Ferrara 5
Fuzhou 5
Ottawa 5
Rozzano 5
Seoul 5
Tokyo 5
Washington 5
Changchun 4
Chengdu 4
Enterprise 4
Jinan 4
Phoenix 4
Rivignano 4
Toowoomba 4
Atlanta 3
Bologna 3
Campolongo Maggiore 3
Castignano 3
Central 3
Clearwater 3
Copenhagen 3
Hounslow 3
Kuala Lumpur 3
Lagos 3
Totale 3.860
Salva come PNG Salva come JPEG
Nome #
The prognostic significance of the Birmingham Vasculitis Activity Score (BVAS) with systemic vasculitis patients transferred to the intensive care unit (ICU) 321
B CELL DEPLETION IN DIFFUSE PROGRESSIVE SYSTEMIC SCLEROSIS: SAFETY, SKIN SCORE MODIFICATION AND IL-6 MODULATION IN AN UP TO THIRTY-SIX MONTHS FOLLOW-UP OPEN-LABEL TRIAL 240
B cell subsets in the joint compartments of seropositive and seronegative RA and non-RA arthritides express memory markers and ZAP-70 and characterize the aggregate pattern irrespectively of the autoantibody status. 191
Impatto dell’inquinamento ambientale da benzene e PM10 sulla progressione clinica della sclerosi sistemica: un’analisi di correlazione. 183
Synovial fluid-derived T helper 17 cells correlate with inflammatory activity in arthritis, irrespectively of diagnosis. 166
MR imaging of atlantoaxial joint in early rheumatoid arthritis. 161
Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization 147
Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: Potential utility of immunosuppressive therapy in cardiac damage progression 144
Proteomic approaches to Sjögren's syndrome: a clue to interpret the pathophysiology and organ involvement of the disease. 138
A vascular endothelial growth factor deficiency characterises scleroderma lung disease 132
Atlantoepistrophic magnetic resonance imaging involvement in early rheumatoid arthritis: an aggressive tight control therapy not fully arresting the disease 131
Very early rheumatoid arthritis is the major predictor of major outcome: clinical ACR remission and radiographic non-progression. 126
beta-thymosins and interstitial lung disease: study of a scleroderma cohort with a one-year follow-up 125
B CELLS IN SYSTEMIC SCLEROSIS: A POSSIBLE TARGET FOR THERAPY 119
Preserved cardiorespiratory function and NT-proBNP levels before and during exercise in patients with recent onset of rheumatoid arthritis: the clinical challenge of stratifying the patient cardiovascular risks 118
Memory B cell subsets and plasmablasts are lower in early than in long-standing rheumatoid arthritis 117
Assessment of neurological manifestations in hospitalized patients with COVID-19 116
Long-term efficacy of B cell depletion therapy on lung and skin involvement in diffuse systemic sclerosis 114
Detection of bone erosions in early rheumatoid arthritis: 3D ultrasonography versus computed tomography 114
(AS) TNF-alpha blockade induces a reversible but transient effect on endothelial dysfunction in patients with long-standing severe rheumatoid arthritis. 110
Allele *2 of the HS1,2A enhancer of the Ig regulatory region associates with rheumatoid arthritis 110
Proteome analysis of biological fluids from autoimmune-rheumatological disorders 108
ENVIRONMENTAL POLLUTION AND SYSTEMIC SCLEROSIS: A PILOT STUDY ON BENZENE AND PARTICULATE EXPOSURE AS RISK FACTORS FOR THE SYSTEMIC MANIFESTATIONS 107
Prognostic Role of Ventricular Ectopic Beats in Systemic Sclerosis: A Prospective Cohort Study Shows ECG Indexes Predicting the Worse Outcome 107
Tumour-associated antigens in systemic sclerosis patients with interstitial lung disease: association with lung involvement and cancer risk 104
Prognostic Role of Ventricular Ectopic Beats in Systemic Sclerosis: A Prospective Cohort Study Shows ECG Indexes Predicting the Worse Outcome 98
Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease 98
Clinical and ultrasonographic remission determines different chances of relapse in early and long standing rheumatoid arthritis. 97
Preserved cardiorespiratory function and NT-proBNP levels before and during exercise in patients with recent onset of rheumatoid arthritis: the clinical challenge of stratifying the patient cardiovascular risks 87
Tumour-associated antigens in systemic sclerosis patients with interstitial lung disease: association with lung involvement and cancer risk 86
Quantitative and semi-quantitative computed tomography analysis of interstitial lung disease associated with systemic sclerosis: A longitudinal evaluation of pulmonary parenchyma and vessels 86
Environmental pollution and systemic sclerosis manifestations: a pilot study on benzene and particulate exposure 85
Life-threatening arrhythmias in a scleroderma patient: the role of myocardial inflammation in arrhythmic outburst 84
Baseline shoulder ultrasonography is not a predictive marker of response to glucocorticoids in patients with polymyalgia rheumatica: A 12-month followup study 83
Improved Endothelial Function After Endothelin Receptor Blockade in Patients With Systemic Sclerosis 80
Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: potential utility of immunosuppressive therapy in cardiac damage progression 79
Characterization of inflammatory cell infiltrate of scleroderma skin: B cells and skin score progression. 76
Cardiac troponin T and NT-proBNP as diagnostic and prognostic biomarkers of primary cardiac involvement and disease severity in systemic sclerosis: A prospective study 76
Sarilumab use in severe SARS-CoV-2 pneumonia 75
The human salivary proteome: a critical overview of the results obtained by different proteomic platforms 72
Immunosuppressive Therapy (Methotrexate or Cyclophosphamide) in Combination with Corticosteroids in the Treatment of Giant Cell Arteritis: Comparison with Corticosteroids Alone 72
Very early rheumatoid arthritis as a predictor of remission: a multicentre real life prospective study 70
Adult-onset Still's disease following COVID-19 vaccination 70
Thymosin β4 and β10 in Sjögren's syndrome: Saliva proteomics and minor salivary glands expression 69
No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic 68
Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease 64
Adult Onset Still's Disease and Radiotherapy treatment for breast cancer: Case report about management of this rare association and literature review 64
Interleukin-6 and IgA-rheumatoid factor are crucial for baseline erosiveness, and anti-citrullinated peptide antibodies for radiographic progression in early rheumatoid arthritis treated according to a treat-to-target strategy 63
Free light chains of immunoglobulins in patients with systemic sclerosis: correlations with lung involvement and inflammatory milieu 62
Computer-aided quantification of interstitial lung disease from high resolution computed tomography images in systemic sclerosis: correlation with visual reader-based score and physiologic tests 60
Troponin in Stable Ischemic Heart Disease and Diabetes 59
FUNZIONE CARDIORESPIRATORIA, ARTERIAL STIFFNESS E LIVELLI DI NT-PRO BNP IN PAZIENTI AFFETTI DA ARTRITE REUMATOIDE ALL’ESORDIO 58
An unusual lung involvement in scleroderma: lipoid pneumonia 57
Troponin in Stable Ischemic Heart Disease and Diabetes 56
No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic 55
Subclinical atherosclerosis and endothelial dysfunction in patients with polymyalgia rheumatica: a pilot study 52
Gut microbiota analysis in systemic sclerosis according to disease characteristics and nutritional status 52
Very early rheumatoid arthritis as a predictor of remission: a multicentre real life prospective study 49
Arthritis in systemic vasculitis: a retrospective analysis 49
Microvascular heart involvement in systemic autoimmune diseases: The purinergic pathway and therapeutic insights from the biology of the diseases 47
Sixth-month remission as a predictor for twelve-month remission in polymyalgia rheumatica 47
Treatment strategy introducing immunosuppressive drugs with glucocorticoids ab initio or very early in giant cell arteritis: A multicenter retrospective controlled study 45
Measuring the T-cell down-regulation of TCR-zeta, ZAP-70 and CD28 in arthritis patients: An old tool for new biomarkers 40
Multidisciplinary Evaluation of Interstitial Lung Diseases: New Opportunities Linked to Rheumatologist Involvement 40
Long-term efficacy of B cell depletion therapy on lung and skin involvement in diffuse systemic sclerosis 39
Chronic related group classification system as a new public health tool to predict risk and outcome of COVID-19 in patients with systemic rheumatic diseases: A population-based study of more than forty thousand patients 38
Ecografia delle spalle in pazienti con PR: valore diagnostico ma non predittivo 38
The role of PET/CT in connective tissue disorders: systemic sclerosis, Sjögren's syndrome and systemic lupus erythematosus 32
Reply to: Individuality of the composition of the human microbiota 32
Extension of Lung Damage at Chest Computed Tomography in Severely Ill COVID-19 Patients Treated with Interleukin-6 Receptor Blockers Correlates with Inflammatory Cytokines Production and Prognosis 28
The role of PET/CT in connective tissue disorders: systemic sclerosis, Sjögren's syndrome and systemic lupus erythematosus 26
Sudden winter iloprost withdrawal in scleroderma patients during COVID-19 pandemic 25
Sixth-month remission as a predictor for twelve-month remission in polymyalgia rheumatica 25
Sex-related Differences in Systemic Sclerosis: A Multicenter Cross-sectional Study From the National Registry of the Italian Society for Rheumatology 24
Lung ultrasound predicts non-invasive ventilation outcome in COVID-19 acute respiratory failure: a pilot study 22
What can we learn from rapidly progressive interstitial lung disease related to anti-MDA5 dermatomyositis in the management of COVID-19? 22
Survival and prognostic factors from a multicentre large cohort of unselected Italian systemic sclerosis patients 21
Risk of burnout and stress in physicians working in a COVID team: A longitudinal survey 19
Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing Therapies 18
Concordance and Prognostic Relevance of Different Definitions of Systemic Sclerosis Interstitial Lung Disease Progression 17
COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes 17
Lung vascular changes as biomarkers of severity in systemic sclerosis-associated interstitial lung disease 16
Low-dose oral imatinib in the treatment of systemic sclerosis interstitial lung disease unresponsive to cyclophosphamide: a phase II pilot study 16
Letter: prevalence and patterns of gastrointestinal symptoms in a large Western cohort of patients with COVID-19 16
Adherence to the Mediterranean Diet in Italian Patients With Systemic Sclerosis: An Epidemiologic Survey 15
Systemic sclerosis progression INvestiGation (SPRING) Italian registry: Demographic and clinico-serological features of the scleroderma spectrum 15
Environmental Pollution by Benzene and PM10 and Clinical Manifestations of Systemic Sclerosis: A Correlation Study 15
COVID-19 and intestinal inflammation: Role of fecal calprotectin 15
Gemelli decision tree Algorithm to Predict the need for home monitoring or hospitalization of confirmed and unconfirmed COVID-19 patients (GAP-Covid19): preliminary results from a retrospective cohort study 15
COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes 15
Interstitial Lung Disease Associated With Autoimmune Rheumatic Diseases: Checklists for Clinical Practice 14
Preserved cardiorespiratory function and NT-proBNP levels before and during exercise in patients with recent onset of rheumatoid arthritis: the clinical challenge of stratifying the patient cardiovascular risks 14
Interleukin-6 and IgA-rheumatoid factor are crucial for baseline erosiveness, and anti-citrullinated peptide antibodies for radiographic progression in early rheumatoid arthritis treated according to a treat-to-target strategy 14
Ultrasonography involvement of carotid, upper and lower limb arteries in a large cohort of systemic sclerosis patients 14
Comment on: Skin improvement is a surrogate for favourable changes in other organ systems in early diffuse cutaneous systemic sclerosis 13
Real-life efficacy and safety of nintedanib in systemic sclerosis-interstitial lung disease: data from an Italian multicentre study 13
Synovial B cells of rheumatoid arthritis express ZAP-70 which increases the survival and correlates with the inflammatory and autoimmune phenotype 13
Geographical heterogeneity of clinical and serological phenotypes of systemic sclerosis observed at tertiary referral centres. The experience of the Italian SIR-SPRING registry and review of the world literature 13
More to B: the growing evidence to inform targeting B cells in scleroderma 13
Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry 'SPRING' of the Italian Society for Rheumatology 12
Totale 6.893
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.145
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.145
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020577 0 0 0 0 72 128 79 30 30 63 124 51
2020/2021747 29 54 197 49 87 21 51 20 87 28 107 17
2021/2022800 54 38 23 56 61 44 36 102 39 86 106 155
2022/20231.685 214 235 127 271 83 191 83 138 152 14 56 121
2023/20241.067 36 278 53 57 38 146 73 76 21 31 149 109
2024/2025588 49 51 218 85 185 0 0 0 0 0 0 0
Totale 7.128